| Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and … RA Kyle, BGM Durie, SV Rajkumar, O Landgren, J Bladé, G Merlini, ... Leukemia 24 (6), 1121-1127, 2010 | 1105 | 2010 |
| Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet T Barbui, G Barosi, G Birgegard, F Cervantes, G Finazzi, M Griesshammer, ... Journal of clinical oncology 29 (6), 761-770, 2011 | 1086 | 2011 |
| Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study SK Kumar, JH Lee, JJ Lahuerta, G Morgan, PG Richardson, J Crowley, ... Leukemia 26 (1), 149-157, 2012 | 1000 | 2012 |
| International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the Mount Sinai Acute GVHD International Consortium AC Harris, R Young, S Devine, WJ Hogan, F Ayuk, U Bunworasate, ... Biology of Blood and Marrow Transplantation 22 (1), 4-10, 2016 | 803 | 2016 |
| Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey R Zeiser, A Burchert, C Lengerke, M Verbeek, K Maas-Bauer, ... Leukemia 29 (10), 2062-2068, 2015 | 631 | 2015 |
| Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet T Barbui, A Tefferi, AM Vannucchi, F Passamonti, RT Silver, R Hoffman, ... Leukemia 32 (5), 1057-1069, 2018 | 628 | 2018 |
| Antilymphocyte globulin for prevention of chronic graft-versus-host disease N Kröger, C Solano, C Wolschke, G Bandini, F Patriarca, M Pini, A Nagler, ... New England Journal of Medicine 374 (1), 43-53, 2016 | 609 | 2016 |
| Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annually JR Passweg, H Baldomero, P Bader, C Bonini, S Cesaro, P Dreger, ... Bone marrow transplantation 51 (6), 786-792, 2016 | 584 | 2016 |
| Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European … O Penack, M Marchetti, T Ruutu, M Aljurf, A Bacigalupo, F Bonifazi, ... The Lancet Haematology 7 (2), e157-e167, 2020 | 524 | 2020 |
| The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies E Carreras, C Dufour, M Mohty, N Kröger Springer Nature, 2019 | 505 | 2019 |
| Indications for allo-and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015 A Sureda, P Bader, S Cesaro, P Dreger, RF Duarte, C Dufour, ... Bone marrow transplantation 50 (8), 1037-1056, 2015 | 498 | 2015 |
| Sorafenib Maintenance After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia With FLT3–Internal Tandem Duplication Mutation … A Burchert, G Bug, LV Fritz, J Finke, M Stelljes, C Röllig, E Wollmer, ... Journal of Clinical Oncology 38 (26), 2993-3002, 2020 | 492 | 2020 |
| Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party … N Kröger, E Holler, G Kobbe, M Bornhäuser, R Schwerdtfeger, ... Blood, The Journal of the American Society of Hematology 114 (26), 5264-5270, 2009 | 491 | 2009 |
| International Myeloma Working Group recommendations for the diagnosis and management of myeloma-related renal impairment MA Dimopoulos, P Sonneveld, N Leung, G Merlini, H Ludwig, E Kastritis, ... Journal of Clinical Oncology 34 (13), 1544-1557, 2016 | 476 | 2016 |
| Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report JR Passweg, H Baldomero, P Bader, C Bonini, RF Duarte, C Dufour, ... Bone marrow transplantation 52 (6), 811-817, 2017 | 450 | 2017 |
| Revised response criteria for myelofibrosis: international working group-myeloproliferative neoplasms research and treatment (IWG-MRT) and European LeukemiaNet (ELN) consensus … A Tefferi, F Cervantes, R Mesa, F Passamonti, S Verstovsek, ... Blood, The Journal of the American Society of Hematology 122 (8), 1395-1398, 2013 | 423 | 2013 |
| International Myeloma Working Group consensus approach to the treatment of multiple myeloma patients who are candidates for autologous stem cell transplantation M Cavo, SV Rajkumar, A Palumbo, P Moreau, R Orlowski, J Bladé, ... Blood, The Journal of the American Society of Hematology 117 (23), 6063-6073, 2011 | 423 | 2011 |
| Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel T De Witte, D Bowen, M Robin, L Malcovati, D Niederwieser, ... Blood, The Journal of the American Society of Hematology 129 (13), 1753-1762, 2017 | 415 | 2017 |
| Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice T Ruutu, A Gratwohl, T De Witte, B Afanasyev, J Apperley, A Bacigalupo, ... Bone marrow transplantation 49 (2), 168-173, 2014 | 408 | 2014 |
| Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years JR Passweg, H Baldomero, C Chabannon, GW Basak, R de La Cámara, ... Bone marrow transplantation 56 (7), 1651-1664, 2021 | 387 | 2021 |